Friday, 20 July 2018 - 9:40
  • it
  • de
  • en
  • fr

Vaccines

Vaccines: Sanofi acquires Protein Science

Sanofi announced it has completed the acquisition of Protein Sciences, a US-based biotech company focusing on vaccines. Thanks to this acquisition, Sanofi Pasteur can now add a promising influenza vaccine to its portfolio: Flublok. It is the only recombinant protein-based…

The difficulties and contradictions of vaccine industry

The prestigious journal The Lancet launched this week the Vaccines Index, an assessment of public and private entities operating in the vaccine industry. The Index, however, is currently limited to 8 entities, producing vaccines for 69 diseases and selling in…

GSK, new R&D center for vaccines

GlaxoSmithKline is planning to create a global vaccine R&D center in Rockville, Maryland. This new hub will boast 450 scientists and the available state-of-the-art technologies, the company informed. The decision comes a year and a half after GSK acquired Novartis’…

Big Pharma: the companies with drugs and vaccines essential for public health

Access to Medicine Foundation performed an analysis to identify the pharmaceutical companies which have essential drugs and vaccines on the market. The report was prepared by comparing the pharmaceutical companies’ product portfolios with the Model Essential Medicines List (EML), compiled…

WHO: Janssen completes application for Ebola vaccine

Janssen Vaccines & Prevention B.V., part of the Johnson & Johnson group, has completed its application to the World Health Organization (WHO) for an Emergency Use Assessment and Listing (EUAL) for its investigational preventive Ebola vaccine. EUAL is a procedure…